Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications.

Autor: Godman B; Division of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden.; Division of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.; Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.; School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia., Hill A; Institute of Translational Medicine, University of Liverpool, UK., Simoens S; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Belgium., Selke G; Wissenschaftliches Institut Der AOK (WIdO), Berlin, Germany., Selke Krulichová I; Department of Medical Biophysics, Faculty of Medicine in Hradec Králové, Charles University, Hradec, Králové, Czech Republic., Zampirolli Dias C; Faculty of Pharmacy, Postgraduate Program in Medicines and Pharmaceutical Services, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.; SUS Collaborating Centre for Technology Assessment and Excellence in Health (CCATES), Belo Horizonte, Minas Gerais, Brazil., Martin AP; Faculty of Health and Life Sciences, Liverpool, UK.; QC Medica, Sim Balk Lane, York UK., Oortwijn W; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Timoney A; Division of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.; NHS Lothian, Edinburgh, UK., Gustafsson LL; Division of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden., Voncina L; Faculty of Health Studies, Rijeka, Croatia., Kwon HY; Division of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.; Division of Biology & Public Health, Mokwon University, Daejeon, Korea., Gulbinovic J; Department of Pathology, Forensic Medicine and Pharmacology, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania., Gotham D; Independent Researcher, Boston, MA, United States., Wale J; Independent Consumer Advocate, Brunswick, Victoria, Australia., Cristina Da Silva W; Faculty of Pharmacy, Postgraduate Program in Medicines and Pharmaceutical Services, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.; Data and Knowledge Integration Center for Health(CIDACS), Fundação Oswaldo Cruz (FIOCRUZ)/ Salvador, Bahia, Brazil., Bochenek T; Department of Nutrition and Drug Research, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland., Allocati E; Istituto Di Ricerche Farmacologiche 'Mario Negri' IRCCS, Milan, Italy., Kurdi A; Division of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.; Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.; Department of Pharmacology, College of Pharmacy, Hawler Medical University, Erbil, Iraq., Ogunleye OO; Department of Pharmacology, Therapeutics and Toxicology, Lagos State University College of Medicine, Ikeja, Lagos, Nigeria.; Department of Medicine, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria., Meyer JC; Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa., Hoxha I; Department of Pharmacy, Faculty of Medicine, University of Medicine, Tirana, Albania., Malaj A; University of Medicine, Tirana, Albania., Hierländer C; Department of Pharmaceutical Affairs, Federation of Social Insurances, Vienna, Austria., Sauermann R; Department of Pharmaceutical Affairs, Federation of Social Insurances, Vienna, Austria., Hamelinck W; Statistics Department, Bruxelles, Belgium., Petrova G; Faculty of Pharmacy, Department of Social Pharmacy and Pharmacoeconomics, Medical University of Sofia, Sofia, Bulgaria., Laius O; State Agency of Medicines, Tartu, Estonia., Langner I; Wissenschaftliches Institut Der AOK (WIdO), Berlin, Germany., Yfantopoulos J; School of National and Kapodistrian University of Athens Athens Greece., Joppi R; Pharmaceutical Drug Department, Azienda Sanitaria Locale of Verona, Verona, Italy., Jakupi A; Faculty of Pharmacy, UBT - Higher Education Institution, Prishtina, Kosovo., Greiciute-Kuprijanov I; Department of Pharmacy, Ministry of Health of the Republic of Lithuania, Vilnius, Lithuania., Vella Bonanno P; Division of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK., Piepenbrink JH; National Health Care Institute (ZIN), XH, Diemen, Netherlands., de Valk V; National Health Care Institute (ZIN), XH, Diemen, Netherlands., Wladysiuk M; HTA Consulting, Cracow, Poland., Marković-Peković V; Faculty of Medicine, Department of Social Pharmacy, University of Banja Luka, Banja Luka, Republic of Srpska, Bosnia and Herzegovina., Mardare I; Faculty of Medicine, Public Health and Management Department, 'Carol Davila' University of Medicine and Pharmacy Bucharest, Bucharest, Romania., Fürst J; Health Insurance Institute, Ljubljana, Slovenia., Tomek D; Faculty of Medicine, Slovak Medical University in Bratislava, Bratislava, Slovakia., Obach Cortadellas M; Drug Department, Catalan Health Service, Catalan Health Service, Barcelona, Spain., Zara C; Drug Department, Catalan Health Service, Catalan Health Service, Barcelona, Spain., Pontes C; Drug Department, Catalan Health Service, Catalan Health Service, Barcelona, Spain.; Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma De Barcelona, Barcelona, Spain., McTaggart S; Public Health Scotland, Edinburgh, UK., Laba TL; Centre for Health Economics Research and Evaluation, University of Technology Sydney, Broadway, Sydney, NSW., Melien Ø; Reviews and Health Technology Assessments, Norwegian Institute of Public Health, Oslo, Norway., Wong-Rieger D; Health Data Science, Institute of Population Health, Liverpool, Canadian Organization for Rare Disorders, Toronto, Ontario, Canada., Bae S; College of Pharmacy, Ewha Woman's University, Seoul, South Korea., Hill R; Health Data Science, Institute of Population Health Liverpool Reviews and Implementation Group, Whelan Building, University of Liverpool, Liverpool, UK.

Publikováno v: Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2021 Aug; Vol. 21 (4), pp. 527-540. Date of Electronic Publication: 2021 Mar 11.

[The increase in the use of drug treatment for diabetes mellitus in the Netherlands, 1998-2003].

Autor: Langendam MW; College voor zorgverzekeringen, sector Genees- en hulpmiddelen Informatie Project Diemen. mlangendam@cvz.nl, Hooijkaas C, Piepenbrink JF

Publikováno v: Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2006 Jun 24; Vol. 150 (25), pp. 1396-401.